top of page
For CNS diseases, patients must be – and now can be – at the center of discovering new treatments.
DaCapo begins with data from patients.
We combine novel techniques developed by our founders in neuroscience, machine learning and stem-cell technologies to identify new targets and new categories of disease within larger heterogeneous CNS diseases.
Our founders built this approach to address fundamental challenges in these diseases.
Our name comes from the musical term da capo, which means “from the head”. This term tells a musician to return to the beginning and play the music again, but to follow it to a new place, just as we hope to help patients find new paths forward.
bottom of page